Tscan Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $256k | 140k | 1.82 |
| 2025-06-30 | $223k | 154k | 1.45 |
| 2025-03-31 | $156k | 113k | 1.38 |
| 2024-12-31 | $322k | 106k | 3.04 |
| 2024-09-30 | $191k | 38k | 4.98 |
| 2024-06-30 | $224k | 38k | 5.85 |
| 2024-03-31 | $503k | 63k | 7.94 |
| 2023-09-30 | $226k | 88k | 2.56 |
| 2023-06-30 | $125k | 50k | 2.50 |
| 2023-03-31 | $242k | 115k | 2.10 |
| 2022-12-31 | $188k | 115k | 1.63 |
| 2022-09-30 | $351k | 115k | 3.05 |
| 2022-06-30 | $362k | 115k | 3.15 |
| 2022-03-31 | $322k | 115k | 2.80 |
| 2021-12-31 | $180k | 40k | 4.50 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management